Friday, July 31, 2026

North Korea’s Drone Intrusions: What Experts Say About the 2024 and 2026 Incidents

North Korea's drone incursions are linked to anti-South sentiment, aiming to influence public opinion ahead of the 9th Party Congress.

Roborock Dominates Global Smart Cleaning Robot Market in 2025: What Sets It Apart?

Roborock leads the global smart cleaning robot market in 2025, with 5.8M units shipped and a 17.7% market share.

2026: Will North Korea’s Nuclear Freeze Open the Door to U.S. Talks?

Experts urge South Korea to prepare for phased denuclearization talks with North Korea and the U.S., balancing engagement and pressure.

Tag: Lirafugratinib

HLB’s Liraglutide: A Game-Changer in Cholangiocarcinoma Treatment with FDA Priority Review

HLB's Elevar Therapeutics receives FDA Priority Review for lirafugratinib, a promising treatment for cholangiocarcinoma with a 47% response rate.

HLB Group Unveils Groundbreaking Cancer Treatments at AACR 2026: What You Need to Know

HLB Group will present key findings on anti-cancer therapies at AACR 2026, highlighting SynKIR-110 and Lirafugratinib's advancements.

Top News

- Our Sponsors Ad -

Follow us